Introduction
Since its discovery in 1964, Epstein-Barr virus (EBV) has been implicated in the pathogenesis of several types of B-cell malignancies including Burkitt's lymphoma, Hodgkin's disease, and lymphomas arising in immunocompromised individuals. [1] [2] [3] [4] [5] EBV can infect and immortalize human B lymphocytes both in vivo and in vitro and give rise to permanent lymphoblastoid cell lines. [6] [7] [8] Several interacting mechanisms may contribute to immortalization of these cells. Of interest in this regard are experiments demonstrating that lymphotoxin (also known as tumor necrosis factor-b (TNF-b)) is an autocrine growth factor for EBV-infected B-cell lines. [9] [10] [11] [12] [13] Despite the critical impact of high levels of constitutively produced lymphotoxin on the proliferative capacity of these cells, the molecular mechanisms driving overexpression remain to be elucidated.
The EBV-derived latent membrane protein 1 (LMP1) acts as a constitutively active receptor that mimics a cellular growth signal, which normally results from the binding of CD40 ligand to its receptor. 14, 15 In cells expressing LMP1, this function is at least partly responsible for transformation. 16, 17 Like CD40, the C-terminal of LMP1 (located on the inner surface of the plasma membrane) associates with tumor necrosis factor-associated factors (TRAFs). 14, [18] [19] [20] [21] [22] [23] At least four signaling pathways, namely NF-kB, c-Jun N-terminal kinase, p38 MAPK (mitogen activated protein kinase), and JAK/STAT (Janus kinase signal transducers and activators of transcription), are subsequently activated by LMP1. [24] [25] [26] [27] With regard to NF-kB, it has been shown that LMP1 mimics the phosphorylating action of the IkB kinase and, hence, increases NF-kB activation by up to 30-fold. [28] [29] [30] Of interest, the lymphotoxin gene contains a high-affinity kB element, which, when bound to the NF-kB transcription factor, contributes to the production of lymphotoxin. 31, 32 However, a direct relationship between LMP1, NF-kB activation, and lymphotoxin production in EBV-infected lines has not been explored.
Herein, we demonstrate that (i) expression of LMP1 is associated with high levels of lymphotoxin in EBV-immortalized B cells and in B cells stably transfected with a tetracyclineinducible construct; (ii) LMP1 expression by these cells is associated with NF-kB activation; and (iii) inhibition of NF-kB activation results in a marked suppression of lymphotoxin production. These results indicate that EBV-derived LMP1 is critical to the induction of autocrine lymphotoxin expression, and that these effects are mediated via NF-kB activation.
Materials and methods

Cell lines
The cell line Z-43 is a human lymphoblastoid cell line, which has been previously characterized and shown to utilize lymphotoxin as an autocrine growth factor. 13 Z-43 is maintained in RPMI 1640 with 10% heat-inactivated fetal calf serum (Gibco-BRL, Grand Island, NY, USA). The control cell line Daudi is a well-characterized, EBV-positive, Burkitt's lymphoma-derived B-cell line obtained from the American Type Culture Collection (Rockville, MD, USA). Daudi is maintained in RPMI 1640 þ 2 mM glutamine þ 10% fetal calf serum (Gibco-BRL, Grand Island, NY, USA).
The model system cell line 3A4 was a kind gift from Dr Bill Sugden (University of Wisconsin, Madison, WI, USA). The 3A4 cells are a BJAB cell line (a well-characterized EBV-negative Burkitt's-related lymphoma B-cell line 33 ) stably transfected with a tetracycline-inducible full-length, wild-type, functional LMP1 construct. 34 The cells are maintained in RPMI 1640 þ 10% fetal calf serum (Gibco-BRL, Grand Island, NY, USA) in the presence of 1 mg/ml of G418 (neomycin) and 1 mg/ml of puromycin (Sigma, St Louis, MO, USA) to select for cells with the inserted LMP1 gene. For induction of LMP1, a final concentration of 1 or 2 ng/ml of tetracycline was used (Sigma, St Louis, MO, USA) in the media.
Enzyme-linked immunosorbent assay (ELISA)
The ELISA procedures were performed according to the protocol recommended by the manufacturer (R & D Systems, Minneapolis, MN, USA). A standard curve was constructed using recombinant lymphotoxin and is used to assess the levels of lymphotoxin in the media. The lower limit of sensitivity of this assay is 7 pg/ml (as per the manufacturer). This assay is specific for human lymphotoxin and has no species or cytokine crossreactivity (as per the manufacturer). All samples were assayed in duplicate and the mean of the samples was obtained. All experiments were repeated a minimum of three times.
Inhibition of NF-kB
The NF-kB inhibitor Bay 11-7082 (BioMol, Plymouth Meeting, PA, USA) 35 was dissolved in dimethylsulfoxide (DMSO) and used at final concentrations ranging from 0.001 to 500 ng/ml and standardized so that the percentage of DMSO in the media was 0.1%, regardless of Bay 11-7082 concentration. 35 The media of the control cells were supplemented with 0.1% DMSO.
Inhibition of protein synthesis
To determine the stability of lymphotoxin in the media, 1 Â 10 5 cells were grown for 2 days, washed, and plated at a density of 1 Â 10 5 cells/ml in a ratio of 3:1 fresh to old media. We then incubated the cells up to 96 h with the protein synthesis inhibitor cycloheximide (Sigma, St Louis, MO, USA). Cycloheximide was dissolved in DMSO and used at a final concentration of 10 mg/ml and standardized so that the percentage of DMSO in the media was 0.1%. The media of the control cells were supplemented with 0.1% DMSO.
Immunoblots
To verify the presence or absence of LMP1 in our cell lines, immunoblots were performed. Briefly, 1 Â 10 6 cells were isolated by centrifugation and lysed. Loading buffer plus 20% fresh DL-dithiothreitol (DTT) was then added to the samples and the samples were boiled for 5 min. Samples were then loaded on an 8% denaturing polyacrylamide gel (4.6 ml water, 2.7 ml 30% acrylamide, 2.5 ml 1.5 M Tris pH 8.8, 100 ml 10% sodium dodecylsulfate, 100 ml 10% ammonium persulfate, 8 ml TEMED) with a 4% stacking gel. The gel was then run for 1.5 h at room temperature and then transferred to a nitrocellulose membrane support (BioRad, Hercules, CA, USA) for 1.5 h at 101 V, 41C. After transfer, the membrane was blocked with Tris-buffered saline-Tween 0.05% plus 5% nonfat dry milk (50 mM Tris pH 7.5, 200 mM sodium chloride, 0.05% Tween 20, 5% nonfat dry milk) and washed. Block buffer was then added to the membrane and the membrane was incubated with mouse monoclonal LMP1 antibody S-12 or IgG2Ak mouse isotypic control antibody (BD Pharmingen, Lexington, KY, USA) for 2 h at room temperature. 36 The membrane was again washed and then incubated for 1 h at room temperature with anti-mouse Ig horseradish peroxidase-conjugated secondary antibody (Amersham, Little Chalfont, Buckinghamshire, UK). The membrane was developed using the ECL (Amersham, Little Chalfont, Buckinghamshire, UK) chemiluminescence kit according to the manufacturer's protocol and exposed to autoradiographic film and developed. The control antibody used to ensure proper loading of samples on gel was mouse monoclonal antiactin antibody (Sigma, St Louis, MO, USA).
Electrophoretic mobility shift assay (EMSA)
EMSA was used to determine NF-kB activity and its binding to the kB element of the lymphotoxin promoter in our cell lines. A total of 1 Â 10 5 cells were used. Cell pellets were then transferred to ice and resuspended in 400 ml of ice-cold lysis buffer A (10 mM HEPES pH 7.9, 10 mM potassium chloride, 0.1 mM EDTA pH 8.0, 0.1 mM EGTA pH 7.0, 10% human protease inhibitors) (Sigma, St Louis, MO, USA) and incubated for 15 min to allow the cell to swell in a hypotonic solution. For every 400 ml volume, 12.5 ml of 10% Nonidet P-40 was added to the cell suspension followed immediately by a 10 s vortex to lyse the cells and 1 min centrifugation to pellet the nucleus and the cell debris. The cell pellet was then resuspended in 25 ml of icecold lysis buffer B (20 mM HEPES pH 7.9, 400 mM sodium chloride, 1 mM EDTA pH 8.0, 1 mM EGTA pH 7.0, 10% human protease inhibitors) and incubated on ice for 30 min with intermittent vortexing to lyse the cell nuclei. The suspension was then centrifuged at maximum speed for 7 min and the nuclear extract was transferred to a prechilled tube and either used immediately or stored at À801C.
A repeating consensus kB element (5 0 -GGGACTTTCC-3 0 ) double-stranded oligonucleotide was used to bind NF-kB. The DNA probe was labeled with g-32 P dATP and the T4 polynucleotide kinase enzyme. The nuclear extract was added to the binding reaction mixture and then electrophoresed on a 7.5% nondenaturing polyacrylamide gel. The dried gel was developed using a phosphoimager.
The supershift experiments were carried out to ensure that the protein binding to the DNA probe was, in fact, NF-kB. Anti-p50 and -p65 NF-kB supershift antibodies (Santa Cruz Biotech, Santa Cruz, CA, USA) were used.
MTS assay
The MTS assay (CellTiter 96 s AQueous One Solution cell proliferation assay (Promega, Madison, WI, USA)) is a colorimetric method for determining the number of viable cells in proliferation, cytotoxicity, or chemosensitivity assays. Assays are performed according to the manufacturer's instructions. Briefly, a small amount of the CellTiter 96 s Aqueous One Solution Reagent (a tetrazolium compound (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt; MTS) and an electron coupling reagent (phenazine ethosulfate; PES)) is added directly to culture wells, incubated for 1-4 h and then absorbance is recorded at 490 nm with a 96-well plate reader. The quantity of formazan product as measured by the amount of 490 nm absorbance is directly proportional to the number of living cells in culture.
Antibodies
The mouse monoclonal anti-LMP1 antibody S-12 is an IgG2Ak antibody and was a kind gift from Dr Elliot Kieff (Harvard University Medical School, Boston, MA, USA). 36 The IgG2Ak isotypic control antibody was purchased from BD Pharmingen (Lexington, KY, USA). The mouse monoclonal anti-b-actin antibody was purchased from Sigma (St Louis, MO, USA). The anti-mouse Ig horseradish peroxidase-conjugated secondary antibody was purchased from Amersham (Little Chalfont, Buckinghamshire, UK). The rabbit polyclonal NF-kB-specific anti-p50 (H-119) and anti-p65 (H-286) antibodies used in the EMSAs were purchased from Santa Cruz Biotech (Santa Cruz, CA, USA).
Results
LMP1 expression correlates with lymphotoxin production
Previously, we demonstrated that the EBV-transformed lymphoblastoid B-cell line Z-43 utilized lymphotoxin as an autocrine growth factor. 13 Lymphoblastoid cell lines such as Z-43 should exhibit a latency III pattern of gene expression (which includes LMP1), while EBV-positive type I Burkitt's lymphoma cell lines exhibit a latency I pattern of gene expression (LMP1-negative). 37 To confirm the presence or absence of LMP1, we assessed the steady-state levels of this protein in the Z-43 line and in the Daudi Burkitt's line by immunoblot. The Z-43 cell line produced large amounts of LMP1, while the LMP1 protein was undetectable in the Daudi cells ( Figure 1a) . Next, the lymphotoxin production at 48 h in the LMP1-positive Z-43 cell line was compared to the lymphotoxin production in the LMP1-negative Daudi cell line. Both lines were grown to a density of 1 Â 10 7 cells/ml and the media were assayed by ELISA. The Z-43 cell line produced greater than 350 times the amount of lymphotoxin (1960 pg/ml) than the Daudi cell line (below assay sensitivity, o7 pg/ml) ( Table 1) .
Next, we investigated if LMP1 expression was associated with an increase in lymphotoxin production in the tetracyclineinducible LMP1-transfected model cell line 3A4. The media of two sets of 3A4 cells were supplemented with 1 ng/ml tetracycline (3A4-1) and 2 ng/ml tetracycline (3A4-2) to induce LMP1 expression. On Western blot, the 3A4 cells without tetracycline showed no LMP1 expression, while the LMP1 expression increased corresponding with tetracycline concentration in the 3A4-1 and 3A4-2 cells (Figure 1b) . The lymphotoxin production at 48 h was then compared in the LMP1-negative 3A4 cells to the LMP1-positive 3A4-1 and 3A4-2 cells. Lymphotoxin production was significantly increased in the tetracycline-induced LMP1-positive 3A4-1 (181 pg/ml) and 3A4-2 cells (670 pg/ml) vs the LMP1-negative 3A4 cells (55 pg/ml) ( Table 1) .
LMP1 expression correlates with enhanced NF-kB activation
It has been previously shown that LMP1 activates NF-kB and that the lymphotoxin promoter contains a high-affinity kB element. 28, [30] [31] [32] We carried out EMSAs to determine if the presence of LMP1 correlates with increased NF-kB activation in our cell lines. The LMP1-positive Z-43 and 3A4-2 cells showed significantly higher levels of activated NF-kB as compared to the LMP1-negative 3A4 cells (Figure 2a) . To demonstrate that the retarded band observed by EMSA was indeed NF-kB, we incubated the nuclear extracts with antibody to either p50 (NFkB1) or p65 (Rel A) subunits and then carried out EMSA. The results from this experiment (Figure 2b) show that antibodies to either subunit of NF-kB shifted the band to a higher molecular weight, thus confirming that the NF-kB complex consisted of p50 and p65 subunits. These results suggest that NF-kB can be activated, and therefore bound, in these cells even in the absence of LMP1, but that LMP1 expression is associated with enhanced activation and binding of NF-kB. ) were lysed according to protocol. Cell extracts were normalized for cell count and loaded in each well. Monoclonal anti-LMP1 antibody S-12 was used to detect the presence of LMP1. To ensure equal protein loading, the blot was also exposed to anti-b-actin antibodies. These experiments demonstrate that the lymphoblastoid line Z-43 produces LMP1, whereas the Burkitt's lymphoma line Daudi does not. (b) Immunoblot for LMP1 in the 3A4 (BJAB) cell line stably transfected with a tetracycline-inducible LMP1construct. Cells (1 Â 10 6 ) were lysed according to protocol. Cell extracts were normalized for cell count and loaded in each well. Monoclonal anti-LMP1 antibody S-12 was used to detect the presence of LMP1. 3A4 cells were grown without tetracycline in the media, while 3A4-1 cells were grown with media supplemented with 1 ng/ml tetracycline and 3A4-2 cells were grown with media supplemented with 2 ng/ml tetracycline. To ensure equal protein loading, the blot was also exposed to anti-b-actin antibodies. This experiment demonstrates that 3A4 cells, stably transfected with a tetracyclineinducible LMP1 construct, express LMP1 at levels that correlate with the concentration of tetracycline in the media. LMP1 was detected by immunoblot ( Figure 1 ). c Lower sensitivity of lymphotoxin ELISA is 7 pg/ml.
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NF-kB inhibition decreases lymphotoxin production
To assess the effect of NF-kB binding to the lymphotoxin promoter on the production of lymphotoxin, we inhibited the cytoplasmic activation of NF-kB with Bay 11-7082. Bay 11-7082 is a highly specific, irreversible inhibitor of NF-kB phosphorylation, and therefore activation, and acts by inhibiting the IkB kinase. 35 Increasing concentrations of Bay 11-7082 were added to the LMP1-positive Z-43, 3A4-1 and 3A4-2 cells and the LMP1-negative 3A4 cells; all were plated in fresh media. The media were assayed by ELISA for lymphotoxin production at 48 h. The inhibition of NF-kB activation by Bay 11-7082 was confirmed with EMSA ( Figure 2a, lane 2) and was associated with a dose-dependent decrease in lymphotoxin production in all of the cell lines, regardless of LMP1 presence (Figure 3a, b) . Suppression of NF-kB activation was not due to loss of cell viability; for instance, 34A-2 cells treated with the highest concentration of Bay 11-7082 (500 ng/ml (48 h)) (as used in the experiments to determine effect on NF-kB activation in EMSA (Figure 2a) ) retained 85% viability in the MTS proliferation assay. Degradation of lymphotoxin was not a factor in the decrease of lymphotoxin observed, as lymphotoxin was stable in the media for up to 96 h as demonstrated by our experiments using cycloheximide (Figure 4 ). These data suggest that the major signaling pathway involved in the induction of the lymphotoxin gene in the Z-43 (Figure 3a ) and 3A4 (Figure 3b ) cell lines is mediated through NF-kB. NF-κB c o n tr o l a n t i-p 5 0 a n t i-p 6 5 c o n tr o l a n t i-p 5 0 a n t i-p ) (3A4-2 and Z-43) were lysed and nuclear extracts were obtained. First gel: 3A4-2 cells; second gel: Z-43 cells; third gel: 3A4-2 and Z-43 cells (cold competitor); fourth gel: 3A4-2 and Z-43, using preimmune serum. Samples were normalized for cell count. Samples were incubated with rabbit anti-p50 antibody or rabbit anti-p65 antibody for supershifts and compared to control samples (lane 1). Use of preimmune serum did not result in a supershift (fourth gel). Incubating samples with cold competitor (unlabeled DNA oligonucleotide at 100 molar excess over radiolabeled DNA oligonucleotide) was performed in order to verify that the bands represented NF-kB. These experiments confirm that the transcription factor bound to the radiolabeled DNA probe is NF-kB and that the bound NF-kB contains both the p50 and p65 subunits. Although the mechanism by which these cells are immortalized is largely unknown, over the last several years it has become clear that a critical event in the process is the establishment of an autocrine loop where the cells produce a growth factor that supports their own proliferation. Although several growth factors may contribute to this activity, we have previously demonstrated that lymphotoxin was produced in all of over 200 such lines screened. 13 Lymphotoxin (TNF-b) shares 30% sequence homology with TNF-a, as well as multiple biological activities which overlap to various degrees. 38, 39 However, in our lymphoblastoid lines, lymphotoxin, but not TNF-a, played a crucial, autocrine, growth-promoting role. 13 Herein, we have analyzed the mechanism mediating deregulation of lymphotoxin production and have concentrated on the role of the LMP1 protein. This EBV-derived protein has previously been shown to be important in transformation and can activate NF-kB. 16, 17, [28] [29] [30] Furthermore, the lymphotoxin gene promoter is regulated, at least in part, by the NF-kB transcription factor. 31, 32 The logical extension of these observations was to determine if LMP1 expression is responsible for autocrine lymphotoxin production in EBV-positive B cells. Our current results suggest that it is, and that the key transcriptional intermediate engaged is indeed NF-kB.
Using the Z-43 lymphoblastoid cell line, we found that LMP1 was expressed at high levels ( Figure 1a ) and correlated with lymphotoxin production (Table 1) . Furthermore, these cells contained high levels of activated NF-kB (Figure 2a) , and suppression of NF-kB by Bay 11-7082 (an IkB kinase inhibitor 35 ) resulted in a dose-dependent decrease in lymphotoxin production (Figure 3a) . To further investigate the relationship between LMP1 and lymphotoxin production, we used the 3A4 cell line, 33 which harbored a tetracycline-inducible LMP1 construct. Lymphotoxin production was shown to increase corresponding with tetracycline concentration (and, therefore, LMP1 expression) in the 3A4-1 and 3A4-2 cells (Figure 1b) ( Table 1) . The 3A4 cells, which lacked LMP1 expression, exhibited low lymphotoxin production (Table 1 ) and low NF-kB activation (Figure 2a ), while the 3A4-2 cells with high steadystate levels of LMP1 protein had increased levels of both lymphotoxin (Table 1) and NF-kB activation (Figure 2a) . Similar to the results seen in Z-43 cells, inhibition of NF-kB activation by Bay 11-7082 abrogated lymphotoxin production in a dosedependent manner (Figure 3b) . A previous study of the process responsible for lymphotoxin induction by EBV reported that EBV nuclear antigen 2 (EBNA2) could promote lymphotoxin production, but only at a fraction of the total levels measured in the EBV-transformed B-cell lines. 40 Taken together with our current experiments, these observations suggest that there may be more than one mechanism by which EBV deregulates autocrine lymphotoxin expression. However, it seems likely that the major transcription factor involved in the induction of the lymphotoxin gene is NF-kB, since, in our study, its inhibition resulted in the abrogation of nearly all lymphotoxin production. Of interest, the NF-kB signaling pathway may also be used by other viruses. For instance, it has been demonstrated that the HTLV Tax-1 protein stimulates lymphotoxin production via NF-kB activation in HTLV-infected T cells. 41 EBV infects more than 90% of the human population worldwide and persists for life in infected hosts. [3] [4] [5] Upon primary infection, EBV may cause infectious mononucleosis, a self-limiting lymphoproliferative disorder. It is important that EBV is also believed to participate in the pathogenesis of diverse malignant disorders such as undifferentiated nasopharyngeal carcinoma, Burkitt's lymphoma, and Hodgkin's disease. [3] [4] [5] Moreover, highly lethal EBV-associated lymphoblastoid diseases occur in severe congenital immunodeficiency, in transplant recipients, and in patients with AIDS. The mechanisms underlying the aberrant lymphoproliferative stimulus induced by EBV are unclear and may differ from disease to disease. Elucidation of these mechanisms may have important biologic and therapeutic implications.
Deregulation of cytokine expression contributes to tumorigenesis in diverse ways including driving proliferation, suppressing apoptosis, promoting angiogenesis, and modulating immune response. Our investigations demonstrate that EBVimmortalized B-lymphoblastoid lines express high levels of lymphotoxin, which acts as an autocrine growth factor.
13 LMP1-mediated NF-kB activation appears to play a key role in this process. Since NF-kB activates numerous cytokines, others may also be overexpressed. Interestingly, however, we have previously shown that TNF-a, despite its close relationship to lymphotoxin, does not play a proliferative role. 13 Finally, it is conceivable that molecules which inhibit lymphotoxin activity or its upstream signaling intermediates, including LMP1 and/or NF-kB, may have salutary effects in EBV-driven disorders. Lymphotoxin levels in the media of cycloheximidetreated Z-43 cells. A total of 1 Â 10 5 cells/ml were cultured in 25% old, 75% fresh media to ensure baseline levels of lymphotoxin present at 0 h. Cells were plated with 10 mg/ml cycloheximide in DMSO (final volume of 0.1%) and media were sampled from 0 to 96 h. DMSO minus cycloheximide was used as a control. Lymphotoxin concentrations of the media were analyzed by ELISA. Since cycloheximide inhibits protein synthesis, these experiments demonstrate that lymphotoxin does not degrade in the media for up to 96 h.
